- Home
- TTEC vs CGTX Comparison
TTEC vs CGTX Comparison
Compare TTEC & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTEC | CGTX |
|---|---|---|
| Founded | 1982 | 2007 |
| Country | United States | United States |
| Employees | 69400 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.8M | 94.5M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TTEC | CGTX |
|---|---|---|
| Price | $3.00 | $1.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 515.8K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 40.80 | ★ 62.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,509,171,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.10 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $1.98 | $0.22 |
| 52 Week High | $5.60 | $3.83 |
Technical Indicators
Market Signals| Indicator | TTEC | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 63.65 |
| Support Level | $2.59 | $1.01 |
| Resistance Level | $3.79 | $1.54 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 55.29 | 85.20 |
Price Performance
Historical ComparisonAbout TTEC TTEC Holdings Inc.
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.